Back

Comparison of ticagrelor and prasugrel just before PCI in NSTE acute coronary syndromes, LIKE-ACCOAST analysis

26 August 2023 (15:15 - 16:00)
Organised by: Logo
Congress Presentation Part of: Real-world evidence in acute coronary syndromes (2) Pharmacotherapy ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Professor Zuzana Motovska

Third Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, Prague (Czechia)

8 More presentations in this session

Presentation thumbnail
Temporal trends in severe obesity for patients with ST-elevation myocardial infarctions in patient cohorts stratified by age and gender
Doctor J. Schmucker (Bremen, DE)
Abstract Slides Video
Presentation thumbnail
Real-world impact on mortality of drug adherence to statin, beta-blocker and ACEi/ARB therapy in post-STEMI patients with preserved EF: results from the FAST STEMI registry.
Doctor G. Giannino (Turin, IT)
Abstract Slides Video
Presentation thumbnail
Triglyceride levels predict high-risk coronary artery plaque progression in asymptomatic patients with type 2 diabetes and normal LDL cholesterol
Doctor L. Heinsen (Svendborg, DK)
Abstract Slides Video
Presentation thumbnail
Referral pathway in primary PCI - delays depend on the origin
Doctor F. Dias Claudio (Evora, PT)
Abstract Slides Video
Presentation thumbnail
Temporal trends in the prevalence of cardiovascular and non-cardiovascular comorbidities in patients presenting with acute myocardial infarction: Insights from the AMIS Plus registry
Mr J. Loosli (Zurich, CH)
Abstract Slides Video

Access the full session

Session thumbnail
Real-world evidence in acute coronary syndromes (2)

The Event

Event poster

ESC Congress 2023

26 August 2023 15:15 CET
You may be interested in
thumbnail
Congress Presentation
Comparative effectiveness of prasugrel and ticagrelor among patients undergoing contemporary PCI: insights from the BMC2 registry
thumbnail
Congress Presentation
Evaluating the safety and efficacy of ticagrelor vs. clopidogrel following percutaneous coronary intervention in chronic coronary disease
thumbnail
Congress Presentation
Implementation of prasugrel and prognostic outcomes after percutaneous coronary intervention for myocardial infarction: a nationwide observational study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources